Regulatory Affairs Professionals Society· @RAPSorg · X·· 2026-10-17精选AI 评分60
AI 导读
FDA 于 10 月 14 日宣布启动一项新计划,拟建立“优化、适配目的”的框架,以促进罕见病疗法的开发与上市。该机构称该框架旨在为罕见病治疗药物的研发和商业化提供支持。
推荐理由
FDA 拟为罕见病疗法建立适配的审评框架,读者可据此了解监管层对罕见病开发路径的调整方向。
正文
A new initiative from FDA aims to develop “an optimized, fit-for-purpose” framework to facilitate the development and marketing of treatments for rare diseases, according to a 14 October announcement from the agency.
https://hubs.la/Q04BnC390
来源:Regulatory Affairs Professionals Society · x.com